A carregar...
Trimetazidine improves hepatic lipogenesis and steatosis in non-alcoholic fatty liver disease via AMPK-ChREBP pathway
Clinical studies have demonstrated that trimetazidine (TMZ) possesses a synergistic hypolipidemic effect together with statins, but the underlying mechanism remains to be elucidated. The present study aimed to investigate the role of TMZ in non-alcoholic fatty liver disease (NAFLD). By investigating...
Na minha lista:
| Publicado no: | Mol Med Rep |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7411376/ https://ncbi.nlm.nih.gov/pubmed/32705195 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2020.11309 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|